ARCHIVES

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

This article is from The Cancer Letter archive.

Vol. 10 No. 45 | November 23, 1984

Download PDF Visit The Full Archive

Related Articles

Dendritic Cell Vaccine May Boost Median Survival

March 25, 2011

NIH RFA Available

August 3, 2001

“Imaginary Treatments,” “Wonderful Cures”

June 6, 1997

Matrisian, Nelson, to lead review of NCI translational research programs.

September 23, 2005

Other NCI funding opportunities listed.

July 9, 2004

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994